DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Dyspnoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dyspnoea (99)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 99   Next >>

Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-25

Patient:

Reactions: Fatigue, Dyspnoea, Pain

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-03

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-03



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Dyspnoea, Fatigue, Dizziness, DRY Skin

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Start date: 2012-03-30

Ribasphere

Victrelis
    Dosage: 4 df, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-30



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Injection Site Erythema, Dyspnoea, Fatigue, Pruritus, Rash Erythematous, Rash, Thyroid Function Test Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23



Possible PEG-Intron side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Glaucoma, Dyspnoea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, unknown
    End date: 2012-07-13

Procrit
    Dosage: 1 ml, qw
    End date: 2012-07-13

Rebetol
    Dosage: 200 mg, unknown
    Administration route: Oral
    End date: 2012-07-13



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Dyspnoea, Hypotension, Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Ribasphere
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-23



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Fatigue, Rash Generalised, Dyspnoea, Dizziness, Abdominal Pain Upper

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-10

Ribasphere
    Indication: Hepatitis C

Other drugs received by patient: Omeprazole; Losartan Potassium; Ascorbic Acid



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Pulmonary Hypertension, Dyspnoea, Chest Pain

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Ribavirin; Vertex Asepta Balm



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Gallbladder Pain, Glossodynia, Dyspnoea, Rash, Eructation, Dysgeusia, Irritability, Fatigue, Vision Blurred, Parosmia, Cholecystitis, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 micrograms/0.5 milliliters

Rebetol
    Dosage: unk mg, unk

Victrelis
    Dosage: unk mg, unk

Other drugs received by patient: Doxycycline HCL; Lisinopril; Neurontin; Oxycodone HCL; Omeprazole; Viibryd



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Ischaemia, Dyspnoea, Pain, Pancytopenia, Headache, Optic Neuropathy, Fatigue, Ocular Hyperaemia, Dizziness, Influenza Like Illness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-03-01
    End date: 2012-04-01

PEG-Intron
    Dosage: 0.4 ml, unk
    Start date: 2012-04-01

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-01



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Fatigue, Dyspnoea, Pruritus, Injection Site Erythema, Rash Erythematous, Rash, Thyroid Function Test Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23



Possible PEG-Intron side effects in

Reported by a pharmacist from United States on 2012-08-22

Patient:

Reactions: Confusional State, Dyspnoea, Nausea, Anaemia, Rectal Haemorrhage, DRY Skin, Amnesia, Fatigue, Diarrhoea, DRY Mouth, Alopecia, Anorectal Discomfort, Depressed Mood, Injection Site Exfoliation, Aphonia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 microgram, qw, per injection

Rebetol
    Dosage: unk

Other drugs received by patient: Tricor; Micardis; Omega-3-Acid Ethyl Esters; Wellbutrin; Cardura; Vitamin E; Glucosamine



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Metabolic Acidosis, Dyspnoea, Diarrhoea, Hypophagia, Bronchitis, Pyrexia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Boceprevir
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded MK-5172
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Post Trial Therapy
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded PRE Trial Therapy
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: f
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: h
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: c
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: g
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: e
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: d
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: b
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: 4 df, tid
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-06-24

Blinded Therapy

Blinded Therapy

Blinded Therapy

Blinded Therapy
    Indication: Hepatitis C

Blinded Therapy

PEG-Intron
    Indication: Hepatitis C

PEG-Intron
    Dosage: 0.5 ml, qw
    Administration route: Oral
    Start date: 2012-01-10
    End date: 2012-06-19

Peginterferon Alfa-2B
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Placebo
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Rebetol
    Dosage: 3 df, qam
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-10

Rebetol
    Dosage: 3 df, qpm
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-06

Rebetol
    Dosage: 2 df, qpm
    Administration route: Oral
    Start date: 2012-04-07
    End date: 2012-06-24

Rebetol
    Dosage: 2 df, qam
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-06-24

Rebetol
    Dosage: 3 df, qam
    Administration route: Oral
    Start date: 2012-04-17
    End date: 2012-04-30

Rebetol
    Dosage: 2 df, qam
    Administration route: Oral
    Start date: 2012-04-11
    End date: 2012-04-16

Ribavirin
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Other drugs received by patient: Protonix; Paxil; Protonix; Lisinopril; Paxil; Lisinopril



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient:

Reactions: White Blood Cell Count Decreased, Weight Decreased, Dyspnoea, Nausea, Diabetes Mellitus, Hypotension, Anaemia, Rash, Headache, Therapeutic Product Ineffective, Dysgeusia, Fatigue, RED Blood Cell Count Decreased, Asthenia, Lethargy, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2008-01-04
    End date: 2008-10-03

PEG-Intron
    Dosage: unk unk, unknown
    Start date: 2011-08-17
    End date: 2012-04-03

PEG-Intron
    Dosage: unk unk, unknown
    End date: 2009-10-07

PEG-Intron
    Dosage: 0.4 ?g, unknown

PEG-Intron
    Dosage: 0.3 ?g, unknown

Ribavirin
    Dosage: unk unk, unknown
    End date: 2009-10-07

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2008-01-04
    End date: 2008-10-03

Ribavirin
    Dosage: 200 mg, qd

Ribavirin
    Dosage: unk unk, qd

Ribavirin
    Dosage: unk unk, qd
    Start date: 2011-08-17
    End date: 2012-04-03

Ribavirin

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2011-09-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2011-09-14

Other drugs received by patient: Epoetin Alfa



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient:

Reactions: Weight Decreased, Haemoglobin Decreased, Dyspnoea, Transfusion, Decreased Appetite, Hypersomnia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-22

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-20



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-09

Patient:

Reactions: Wrong Technique in Drug Usage Process, Syncope, Dyspnoea, Asthenia, Blood Pressure Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 micrograms, qw
    Indication: Hepatitis C
    Start date: 2012-05-01

Rebetol
    Indication: Hepatitis C

Other drugs received by patient: Tranxene; Effexor; Lisinopril; Synthroid; Paxil; Ondansetron



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-06

Patient:

Reactions: Dyspnoea, Retching, Nausea, Pyrexia, Constipation, Fatigue, Palpitations, Dizziness, Asthenia, Influenza Like Illness

Drug(s) suspected as cause:
Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C

PEG-Intron
    Dosage: 150 ?g, unknown
    Indication: Hepatitis C

Rebetol
    Dosage: 200 mg, unknown
    Indication: Hepatitis C

Other drugs received by patient: Estradiol (+) Norethindrone; Tylenol (Caplet); Neupogen; Prochlorperazine; Procrit; Prozac



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient:

Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-10-25

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-10-25

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-11-23



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient:

Reactions: Dyspnoea, Musculoskeletal Stiffness, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-02-28

Ribasphere
    Indication: Hepatitis C

Telaprevir
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient:

Reactions: Night Sweats, Abdominal Pain, Contusion, Chills, Wheezing, Pyrexia, Change of Bowel Habit, Constipation, Hyperhidrosis, Joint Stiffness, Hepatomegaly, Laboratory Test Abnormal, Fatigue, Haematocrit Decreased, RED Blood Cell Count Decreased, Dizziness, Melaena, White Blood Cell Count Decreased, Dyspnoea, Hepatic Fibrosis, Haemorrhoids, Incorrect Dose Administered, Laceration, Hepatic Steatosis, Haemoglobin Decreased, Impaired Healing, Diarrhoea, Arthralgia, Insomnia, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 microgram, qd

Pegasys
    Dosage: 180mcg,once a week

Rebetol
    Dosage: 1200 mg, qd

Victrelis
    Dosage: 200mg,4tablets,three times a day

Other drugs received by patient: Allegra-D 12 Hour; Omeprazole; Milk Thistle; Zolpidem Tartrate; Citalopram Hydrobromide; Echinacea (Unspecified)



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Greece on 2012-08-01

Patient:

Reactions: Dyspnoea, Fatigue, Pulmonary Embolism, Pleural Effusion, Pyrexia, Cardiac Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 unk, unk
    Indication: Hepatitis C
    Start date: 2011-09-20
    End date: 2012-07-03

Rebetol
    Dosage: 1200 mg, unk
    Indication: Hepatitis C
    Start date: 2011-09-20
    End date: 2012-07-03



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient:

Reactions: Dyspnoea, Anaemia, Rash, Headache, Generalised Oedema, Anxiety, Gastrointestinal Pain, Fatigue, Diarrhoea, Visual Impairment, Depression, Mood Swings, Cough, Decreased Appetite

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-07-16

Ribasphere
    Dosage: unk
    Start date: 2012-04-27
    End date: 2012-07-16

Telaprevir
    Dosage: unk



Possible PEG-Intron side effects in

Reported by a pharmacist from United States on 2012-08-01

Patient:

Reactions: Dyspnoea, Fatigue, Injection Site Reaction, Insomnia, Gastric Disorder

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-06-21

Ribasphere
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Telaprevir
    Dosage: 750 mg, tid
    Indication: Product Used FOR Unknown Indication



Possible PEG-Intron side effects in

Reported by a physician from Hungary on 2012-08-01

Patient:

Reactions: Dyspnoea, Febrile Neutropenia, Bacterial Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 ?g, qw
    Indication: Hepatitis C
    Start date: 2011-10-02

Rebetol
    Dosage: unk

Victrelis

Other drugs received by patient: Bebetina; Famotidine; Allopurinol



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-31

Patient:

Reactions: Dyspnoea, Drug Ineffective, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-01-01
    End date: 2012-06-01

PEG-Intron
    Dosage: unk
    Start date: 2012-06-30
    End date: 2012-07-17

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-01-01
    End date: 2012-06-01

Rebetol
    Dosage: unk
    Start date: 2012-06-30
    End date: 2012-07-17



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient:

Reactions: Dyspnoea, Fatigue, Ocular Hyperaemia, Pain, Dizziness, Headache, Influenza Like Illness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-03-01
    End date: 2012-04-01

PEG-Intron
    Dosage: 0.4 ml, unk
    Start date: 2012-04-01

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-01



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-25

Patient:

Reactions: Dyspnoea, Syncope, Wrong Technique in Drug Usage Process, Blood Pressure Decreased, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 micrograms, qw
    Indication: Hepatitis C
    Start date: 2012-05-01

Rebetol
    Indication: Hepatitis C

Other drugs received by patient: Lisinopril; Ondansetron; Effexor; Synthroid; Paxil; Tranxene



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25

Patient:

Reactions: Vomiting, Rash Generalised, Dyspnoea, Nausea, Anaemia, Headache, Generalised Oedema, Anxiety, Fatigue, Diarrhoea, Mood Swings, Depression, Blindness, Muscle Spasms, Decreased Appetite, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Ribasphere
    Dosage: unk
    Start date: 2012-04-27

Telaprevir



Possible PEG-Intron side effects in

Reported by a physician from Greece on 2012-07-24

Patient:

Reactions: Dyspnoea, Fatigue, Pleural Effusion, Pulmonary Embolism, Pyrexia, Cardiac Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 unk, unk
    Indication: Hepatitis C
    End date: 2012-07-03

Rebetol
    Dosage: 1200 microgram, unk
    Indication: Hepatitis C
    End date: 2012-07-03



Possible PEG-Intron side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-17

Patient: male

Reactions: Fatigue, Dyspnoea, Pruritus, Injection Site Erythema, Rash, Thyroid Function Test Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-23



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017